Micophenolate Mofetil Versus Azathioprine in Myocarditis

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

July 10, 2025

Study Completion Date

July 10, 2025

Conditions
Lymphocytic Myocarditis (Disorder)Heart FailureDilated CardiomyopathyCardiomyopathiesSudden Cardiac Death
Interventions
DRUG

mycophenolate mofetil 2 g per day

mycophenolate mofetil 2 g per day and methylprednisolone in an average starting dose 24 \[24; 32\] mg per day and standard drug therapy for heart failure.

DRUG

azathioprine of 150 [75; 150] mg per day

azathioprine at an average dose of 150 \[75; 150\] mg per day and methylprednisolone in an average starting dose 24 \[24; 32\] mg per day and standard drug therapy for heart failure.

Trial Locations (1)

119435

I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow

All Listed Sponsors
lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT05237323 - Micophenolate Mofetil Versus Azathioprine in Myocarditis | Biotech Hunter | Biotech Hunter